|
Volumn 58, Issue 8, 2013, Pages 568-569
|
Further evidence of an association between a genetic variant in BMP7 and treatment response to SSRIs in major depressive disorder
|
Author keywords
[No Author keywords available]
|
Indexed keywords
CITALOPRAM;
FLUVOXAMINE;
NORTRIPTYLINE;
PAROXETINE;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
DISEASE SEVERITY;
DRUG EFFICACY;
GENE;
GENETIC ASSOCIATION;
GENETIC VARIABILITY;
HUMAN;
LETTER;
MAJOR DEPRESSION;
MONOTHERAPY;
OSTEOGENIC PROTEIN 1 GENE;
REMISSION;
SINGLE NUCLEOTIDE POLYMORPHISM;
TREATMENT RESPONSE;
ADULT;
BONE MORPHOGENETIC PROTEIN 7;
DEPRESSIVE DISORDER, MAJOR;
FEMALE;
GENETIC ASSOCIATION STUDIES;
HUMANS;
LOGISTIC MODELS;
MALE;
POLYMORPHISM, SINGLE NUCLEOTIDE;
SEROTONIN UPTAKE INHIBITORS;
TREATMENT OUTCOME;
|
EID: 84883307541
PISSN: 14345161
EISSN: 1435232X
Source Type: Journal
DOI: 10.1038/jhg.2013.52 Document Type: Letter |
Times cited : (3)
|
References (7)
|